AVL-292 is a covalent, orally active, and highly selective BTK inhibitor with IC50 of <0.5 nM, displaying at least 1400-fold selectivity over the other kinases assayed. Phase 1.
Specifications and Purity: ≥98%
Molecular Formula: C22H22FN5O3
Molecular Weight: 423.44
PubChem CID: 59174488
Isomeric SMILES: COCCOC1=CC=C(C=C1)NC2=NC=C(C(=N2)NC3=CC(=CC=C3)NC(=O)C=C)F
Related Documents: https://aladdin-for-icloud-store.oss-cn-hangzhou.aliyuncs.com/aladdinsci/pdp/sds/1/A127694-SCI_8066ed74b52d9b541f356958d9ebdfc1.pdf
- UPC:
- 42181900
- Condition:
- New
- HazmatClass:
- No
- WeightUOM:
- LB
- MPN:
- A127694-5mg
- CAS:
- 1202757-89-8
- Product Size:
- 5mg
akash.verma@cenmed.com
(732) 447-1115





